Literature DB >> 22301706

Inclusion and exclusion in nutrigenetics clinical research: ethical and scientific challenges.

T Hurlimann1, R Stenne, V Menuz, B Godard.   

Abstract

BACKGROUND/AIMS: There are compelling reasons to ensure the participation of ethnic minorities and populations of all ages worldwide in nutrigenetics clinical research. If findings in such research are valid for some individuals, groups, or communities, and not for others, then ethical questions of justice--and not only issues of methodology and external validity--arise. This paper aims to examine inclusion in nutrigenetics clinical research and its scientific and ethical challenges.
METHODS: In total, 173 publications were identified through a systematic review of clinical studies in nutrigenetics published between 1998 and 2007. Data such as participants' demographics as well as eligibility criteria were extracted.
RESULTS: There is no consistency in the way participants' origins (ancestry, ethnicity, or race) and ages are described in publications. A vast majority of the studies identified was conducted in North America and Europe and focused on 'white' participants. Our results show that pregnant women (and fetuses), minors, and the elderly (≥ 75 years old) remain underrepresented.
CONCLUSION: Representativeness in nutrigenetics research is a challenging ethical and scientific issue. Yet, if nutrigenetics is to benefit whole populations and be used in public and global health agendas, fair representation as well as clear descriptions of participants in publications are crucial.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22301706     DOI: 10.1159/000334853

Source DB:  PubMed          Journal:  J Nutrigenet Nutrigenomics        ISSN: 1661-6499


  4 in total

1.  Risks of nutrigenomics and nutrigenetics? What the scientists say.

Authors:  T Hurlimann; V Menuz; J Graham; J Robitaille; M-C Vohl; B Godard
Journal:  Genes Nutr       Date:  2013-11-29       Impact factor: 5.523

2.  IGF2, LEPR, POMC, PPARG, and PPARGC1 gene variants are associated with obesity-related risk phenotypes in Brazilian children and adolescents.

Authors:  E M Queiroz; A P C Cândido; I M Castro; A Q A Bastos; G L L Machado-Coelho; R N Freitas
Journal:  Braz J Med Biol Res       Date:  2015-04-28       Impact factor: 2.590

3.  The elusive ideal of inclusiveness: lessons from a worldwide survey of neurologists on the ethical issues raised by whole-genome sequencing.

Authors:  Thierry Hurlimann; Iris Jaitovich Groisman; Béatrice Godard
Journal:  BMC Med Ethics       Date:  2017-04-11       Impact factor: 2.652

Review 4.  Confronting diversity in the production of clinical evidence goes beyond merely including under-represented groups in clinical trials.

Authors:  Karien Stronks; Nicolien F Wieringa; Anita Hardon
Journal:  Trials       Date:  2013-06-15       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.